Clinical Trials Browser

Phase 3 × Saline Solution × Thoracic × Clear all

NCT03515837 2024-11-22

MK-3475-789

Phase 3 Completed

492 enrolled 21 charts

Carcinoma, Non-Small-Cell Lung

NCT02578680 2024-09-20

MK-3475-189

Phase 3 Completed

616 enrolled 19 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

NCT03950674 2024-06-10

MK-3475-189

Phase 3 Completed

40 enrolled 20 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT03066778 2022-10-03

KEYNOTE-604

Phase 3 Completed

453 enrolled 23 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

NCT01882621 2016-06-01

Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Neurotoxicity Syndromes

NCT01579188 2012-04-19

LucaVax

Phase 3 Unknown

Inoperable Stage III Non-small Cell Lung Cancer